Personal information

Verified email domains

China

Activities

Employment (3)

Affiliated Hospital of Nantong University: Nantong, Jiangsu, CN

2019-12-01 to present | Attending (Urology)
Employment
Source: Self-asserted source
谢湖阳

南通大学附属医院: 南通, 江苏, CN

2018-07-26 to 2019-11-30 | 住院医师 (泌尿外科)
Employment
Source: Self-asserted source
谢湖阳

Nantong Tumor Hospital: Nantong, Jiangsu, CN

2012-08 to 2014-08 | Resident (General Surgery)
Employment
Source: Self-asserted source
谢湖阳

Education and qualifications (3)

Fudan University Shanghai Cancer Center: Shanghai, Shanghai, CN

2014-09-01 to 2018-06-26 | PhD (Urology)
Education
Source: Self-asserted source
谢湖阳

Fudan University Shanghai Cancer Center: Shanghai, Shanghai, CN

2009-09 to 2012-06 | Master (Urology)
Education
Source: Self-asserted source
谢湖阳

Tongji University Medical College: Shanghai, CN

2004-09 to 2009-07 | Bachelor
Education
Source: Self-asserted source
谢湖阳

Works (10)

Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

Clinical Cancer Research
2018-07-01 | Journal article
Contributors: Hangcheng Fu; Yu Zhu; Yiwei Wang; Zheng Liu; Junyu Zhang; Huyang Xie; Qiang Fu; Bo Dai; Dingwei Ye; Jiejie Xu
Source: check_circle
Crossref

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma

Scientific Reports
2018-04-12 | Journal article
Contributors: Fujiang Xu; Kun Chang; Jian Ma; Yuanyuan Qu; Huyang Xie; Bo Dai; Hualei Gan; Hailiang Zhang; Guohai Shi; Yao Zhu et al.
Source: check_circle
Crossref

High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients

OncoImmunology
2017-11-02 | Journal article
Contributors: Yu Zhu; Zheng Liu; Yiwei Wang; Hangcheng Fu; Zewei Wang; Huyang Xie; Junyu Zhang; Gaoxiang Li; Bo Dai; Dingwei Ye et al.
Source: check_circle
Crossref

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma

Scientific Reports
2017-08-29 | Journal article
Contributors: Fujiang Xu; Kun Chang; Jian Ma; Yuanyuan Qu; Huyang Xie; Bo Dai; Hualei Gan; Hailiang Zhang; Guohai Shi; Yao Zhu et al.
Source: check_circle
Crossref

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma.

2016-07 | Journal article
Contributors: Wang Z; Xie H; Zhou L; Liu Z; Fu H; Zhu Y; Xu L; Xu J
Source: Self-asserted source
谢湖阳 via Europe PubMed Central

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma.

2016-05 | Journal article
Contributors: Xie H; Zhu Y; An H; Wang H; Zhu Y; Fu H; Wang Z; Fu Q; Xu J; Ye D
Source: Self-asserted source
谢湖阳 via Europe PubMed Central

Increased expression of interleukin-8 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma.

2015-10 | Journal article
Contributors: An H; Zhu Y; Xie H; Liu Y; Liu W; Fu Q; Ye D; Xu J
Source: Self-asserted source
谢湖阳 via Europe PubMed Central

Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer

Tumor biology
2014-10-11 | Journal article
Source: Self-asserted source
谢湖阳

Development of a nomogram to predict non-organ-confined bladder urothelial cancer before radical cystectomy

International Urology and Nephrology
2012-09-01 | Journal article
Source: Self-asserted source
谢湖阳

Docetaxel plus prednisone versus mitoxantrone plus prednisone as first-line chemotherapy for metastatic hormone-refractory prostate cancer: long-term effects and safety

Zhonghua Wai Ke Za Zhi
2012-06 | Journal article
Source: Self-asserted source
谢湖阳